“Corrigendum: Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs”, FE, vol. 20, no. 1, Jun. 2019, doi: 10.7175/fe.v20i1.1438.